Thursday, August 07, 2025 1:49:23 PM
💥Today’s Breaking CBD News 💥
https://420intel.com/blog/thc-free-hemp-the-new-buzz
https://www.prnewswire.com/news-releases/cv-sciences-inc-launches-new-line-of-thc-free-gummies-and-softgels-301776708.html
https://www.advantagemedical.com/products/products-plus-cbd-thc-free-100mg-30ct-softgel-827-6083/
https://www.professionalsupplementcenter.com/daily-balance-thc-free-cbd-gummies-by-pluscbd-oil
https://cbd.market/pluscbd-cooling-topical-cbd-roll-on-isolate-thc-free-1-13oz-2000mg-cbd
https://ir.cvsciences.com/press-releases/detail/228/cv-sciences-launches-plushlth-a-new-line-of
https://cbd.market/reviews/pluscbd-brand
https://420intel.com/blog/medical-cannabis-cuts-emergency-care-visits-now
https://www.sciencedirect.com/science/article/abs/pii/S0304394025002022
https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-025-00295-7
https://420intel.com/blog/thc-free-hemp-the-new-buzz
https://www.prnewswire.com/news-releases/cv-sciences-inc-launches-new-line-of-thc-free-gummies-and-softgels-301776708.html
https://www.advantagemedical.com/products/products-plus-cbd-thc-free-100mg-30ct-softgel-827-6083/
https://www.professionalsupplementcenter.com/daily-balance-thc-free-cbd-gummies-by-pluscbd-oil
https://cbd.market/pluscbd-cooling-topical-cbd-roll-on-isolate-thc-free-1-13oz-2000mg-cbd
https://ir.cvsciences.com/press-releases/detail/228/cv-sciences-launches-plushlth-a-new-line-of
https://cbd.market/reviews/pluscbd-brand
https://420intel.com/blog/medical-cannabis-cuts-emergency-care-visits-now
https://www.sciencedirect.com/science/article/abs/pii/S0304394025002022
https://jcannabisresearch.biomedcentral.com/articles/10.1186/s42238-025-00295-7
Bullish
Recent CVSI News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/10/2026 08:04:10 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 09:14:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:06:03 PM
- CV Sciences, Inc. Reports Fiscal Year-End 2025 Financial Results • ACCESS Newswire • 03/26/2026 08:00:00 PM
- CV Sciences, Inc. To Announce Year End and Fourth Quarter 2025 Results On March 26, 2026 • ACCESS Newswire • 03/24/2026 09:00:00 PM
- CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth • ACCESS Newswire • 03/10/2026 09:00:00 PM
- CV Sciences Launches EMPOWR: A Plant-Based Protein + Creatine Formula Designed for Total Wellness • ACCESS Newswire • 02/26/2026 01:30:00 PM
- CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD • ACCESS Newswire • 12/23/2025 12:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 10:19:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 09:04:08 PM
- CV Sciences, Inc. Reports Third Quarter 2025 Financial Results • ACCESS Newswire • 11/13/2025 09:00:00 PM
- CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 • ACCESS Newswire • 11/10/2025 11:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2025 09:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:24:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 09:23:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2025 08:01:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 08:50:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:01:33 PM
